---
schema_version: "secwatch.filing_event.v1"
accession: "0001585364-26-000035"
form_type: "8-K"
ticker: "PRGO"
cik: "0001585364"
company_name: "PERRIGO Co plc"
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:53:48.875411+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Perrigo revises segment reporting; FY2025 includes $1.36B impairment charge

## Summary
- Self Care segment net sales $2,533.5M in FY2025, down from $2,554.3M in FY2024.
- Infant Formula segment net sales $359.0M in FY2025, down from $397.0M in FY2024.
- Adjusted operating income for segments totaled $682.6M in FY2025, consolidated adjusted operating income $622.3M.
- Q4 2025 goodwill impairment of $1.3B plus $33.6M equity method impairment contributed to reported operating loss of $1,122.2M.
- Segment change effective Q1 2026; recast historical data provided for comparability.

## SEC filing metadata
- accession: 0001585364-26-000035
- form_type: 8-K
- ticker: PRGO
- cik: 0001585364
- company_name: PERRIGO Co plc
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585364/000158536426000035/0001585364-26-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585364/000158536426000035/prgo-20260422.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001585364-26-000035
- JSON: https://secwatch.observer/filing/0001585364-26-000035.json
- Plain text: https://secwatch.observer/filing/0001585364-26-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.